415 related articles for article (PubMed ID: 8690764)
1. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir.
Standring-Cox R; Bacon TH; Howard BA
J Virol Methods; 1996 Jan; 56(1):3-11. PubMed ID: 8690764
[TBL] [Abstract][Full Text] [Related]
2. Activity of penciclovir in antiviral assays against herpes simplex virus.
Bacon TH; Howard BA; Spender LC; Boyd MR
J Antimicrob Chemother; 1996 Feb; 37(2):303-13. PubMed ID: 8707740
[TBL] [Abstract][Full Text] [Related]
3. Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus.
Earnshaw DL; Bacon TH; Darlison SJ; Edmonds K; Perkins RM; Vere Hodge RA
Antimicrob Agents Chemother; 1992 Dec; 36(12):2747-57. PubMed ID: 1336346
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV.
Hasegawa T; Kurokawa M; Yukawa TA; Horii M; Shiraki K
Antiviral Res; 1995 Jun; 27(3):271-9. PubMed ID: 8540749
[TBL] [Abstract][Full Text] [Related]
5. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
[TBL] [Abstract][Full Text] [Related]
6. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
[TBL] [Abstract][Full Text] [Related]
7. Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants.
Ida M; Kageyama S; Sato H; Kamiyama T; Yamamura J; Kurokawa M; Morohashi M; Shiraki K
Antiviral Res; 1999 Jan; 40(3):155-66. PubMed ID: 10027650
[TBL] [Abstract][Full Text] [Related]
8. Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines.
Leary JJ; Wittrock R; Sarisky RT; Weinberg A; Levin MJ
Antimicrob Agents Chemother; 2002 Mar; 46(3):762-8. PubMed ID: 11850259
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
10. Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents.
Cotarelo M; Catalán P; Sánchez-Carrillo C; Menasalvas A; Cercenado E; Tenorio A; Bouza E
J Antimicrob Chemother; 1999 Nov; 44(5):705-8. PubMed ID: 10552991
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Chono K; Katsumata K; Suzuki H; Shiraki K
Antiviral Res; 2013 Feb; 97(2):154-60. PubMed ID: 23261844
[TBL] [Abstract][Full Text] [Related]
12. Differences in the Likelihood of Acyclovir Resistance-Associated Mutations in the Thymidine Kinase Genes of Herpes Simplex Virus 1 and Varicella-Zoster Virus.
Fujii H; Harada S; Yoshikawa T; Yamada S; Omura N; Shibamura M; Inagaki T; Kato H; Fukushi S; Saijo M
Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858222
[TBL] [Abstract][Full Text] [Related]
13. Penciclovir susceptibilities of herpes simplex virus isolates from patients using penciclovir cream for treatment of recurrent herpes labialis.
Sarisky RT; Bacon T; Boon R; Locke L; Nguyen TT; Leary J; Esser K; Saltzman R
Antimicrob Agents Chemother; 2002 Sep; 46(9):2848-53. PubMed ID: 12183237
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
[TBL] [Abstract][Full Text] [Related]
15. Comparison of methods for identifying resistant herpes simplex virus and measuring antiviral susceptibility.
Sarisky RT; Crosson P; Cano R; Quail MR; Nguyen TT; Wittrock RJ; Bacon TH; Sacks SL; Caspers-Velu L; Hodinka RL; Leary JJ
J Clin Virol; 2002 Jan; 23(3):191-200. PubMed ID: 11595598
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.
Safrin S; Phan L
Antimicrob Agents Chemother; 1993 Oct; 37(10):2241-3. PubMed ID: 8257152
[TBL] [Abstract][Full Text] [Related]
17. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
18. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus].
Morfin F; Frobert E; Thouvenot D
Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of varicella-zoster virus to acyclovir.
Biron KK; Elion GB
Antimicrob Agents Chemother; 1980 Sep; 18(3):443-7. PubMed ID: 6252836
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of varicella-zoster virus to thymidine analogues.
Machida H
Biken J; 1986 Mar; 29(1):1-6. PubMed ID: 3022708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]